SELEGOS is indicated for the treatment of Parkinson's disease or symptomatic parkinsonism.
SELEGOS may be used alone in early Parkinson's disease to delay, the need for levodopa (with or without decarboxylase inhibitor). SELEGOS may also be used as an adjunct to levodopa (with or without decarboxylase inhibitor).